Hepatitis C virus occurs in six known genotypes and more than fifty subtypes. The hepatitis C virus is harbored in the liver and most people infected with HCV eventually will develop cirrhosis or liver carcinoma. HCV can cause an acute or chronic infection. In chronic infection, the infected person can exhibit signs of chronic hepatitis or be a chronic asymptomatic carrier.
Current treatments for hepatitis C include interferons and other pharmaceuticals.
Hyperthermia provides an inovative method for treating patients infected with hepatitis C virus. Hyperthermia is postulated to have a direct effect on heat-liable viruses, as well as to stimilate the immune system response to viral infection. In a pilot study the potential for hyperthermic treatment of hepatitis C infection was shown to be promising.
Further more current studies substantiate these early TheraGenesis studies.